Saturday, December 13, 2025 | 06:54 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Covaxin, ZyCov-D trails mark 'beginning of the end' of Covid-19: Scientist

The article has been published on the websites of the Press Information Bureau (PIB) and the Vigyan Prasar, which is a body under the ministry

pharmacy, drugs, medicine, pharma companies, pharmaceuticals, vaccine, coronavirus, covid, testing
premium

Press Trust of India New Delhi
The Drug Controller General of India's nod to conduct human trials for Indian Covid-19 vaccine candidates Covaxin and ZyCov-D marks the beginning of the end of the coronavirus pandemic, says an article by a scientist with the Ministry of Science and Technology.

The article has been published on the websites of the Press Information Bureau (PIB) and the Vigyan Prasar, which is a body under the ministry.

Though the PIB article did not have a time-line, the one on the Vigyan Prasar portal said it could take anywhere between 15 to 18 months before licence are issued for the vaccine.